Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AVROBIO Inc

AVRO
Current price
1.3 USD +0.01 USD (+0.78%)
Last closed 1.29 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 57 609 464 USD
Yield for 12 month -19.25 %
1Y
3Y
5Y
10Y
15Y
AVRO
21.11.2021 - 28.11.2021

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are harvested from the patient and then modified with a lentiviral vector to insert the equivalent of a functional copy of the gene that is mutated in the target disease. The company's pipeline includes AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of Gaucher disease type 1, as well as to treat Gaucher disease type 3; AVR-RD-03 that is in preclinical stage for the treatment of Pompe disease; AVR-RD-04, which is in phase 1/2 clinical trial for the treatment of cystinosis; and AVR-RD-05 that is in preclinical stage for the treatment of Hunter syndrome. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 100 Technology Square, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures AVRO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -86 345 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -45.46 %
PEG Ratio
Return On Equity TTM -4.07 %
Wall Street Target Price 2 USD
Revenue TTM
Book Value 2.31 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -0.1 USD
Diluted Eps TTM -0.1 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AVRO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AVRO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AVRO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.5331
Price Book MRQ 0.5644

Financials AVRO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AVRO

For 52 weeks

0.57 USD 1.77 USD
50 Day MA 1.35 USD
Shares Short Prior Month 474 606
200 Day MA 1.33 USD
Short Ratio 0.42
Shares Short 181 458
Short Percent 0.47 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

402.79 USD Microsoft Corporation -0.45 (-0.11%)
Detailed analytics

ETF funds


S

SX7EEX

11.59 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2031.07 USD Gold +9.2 (+0.46%)
Detailed analytics